Clinical SummaryA 51-year-old woman with endometrial cancer whose condition progressed with prior treatments was referred to the MD Anderson Cancer Center Phase I Clinical Trials clinic for treatment with an investigational agent. Initial assessment showed normal liver function test results, although aspartate aminotransferase, alanine aminotransferase, and bilirubin levels were elevated on repeat blood tests several days later. Peak total bilirubin, aspartate aminotransferase, and alanine aminotransferase...